BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Monday reported a loss of $15.7 million in its fourth quarter.
The Burlingame, California-based company said it had a loss of 40 cents per share.
The biopharmaceutical company posted revenue of $1.4 million in the period.
For the year, the company reported that its loss widened to $61.4 million, or $1.59 per share. Revenue was reported as $4.3 million.
Kindred Bio shares have fallen 29% since the beginning of the year. In the final minutes of trading on Monday, shares hit $6, a fall of 34% in the last 12 months.